Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
Conditions: Soft Tissue Sarcoma Adult; Advanced Cancer Interventions: Drug: Association of Nivolumab + Relatlimab; Drug: Nivolumab Sponsors: Institut Bergonié; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials